Clinical and Pathologic Complete Response to Gefitinib in a Patient with SqCLC Harboring EGFR p.E746_S752delinsV Mutation

Overview of attention for article published in OncoTargets and therapy, September 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

The novel EGFR mutations (p.E746_S752delinsI, p.T751_I759delinsG, p.L747_S752delinsAA) in patients with non-small cell lung cancer and the clinical treatment strategy: three case reports

Article in Frontiers in Oncology (September 2023)

Gefitinib

Article in Reactions Weekly (April 2022)